CD36 serves as a potential drug-target to alleviate inflammation in atherosclerosis via leonurine-mediated blockade of its activation pocket.
Saved in:
| Title: | CD36 serves as a potential drug-target to alleviate inflammation in atherosclerosis via leonurine-mediated blockade of its activation pocket. |
|---|---|
| Authors: | Lin, Ge1 (AUTHOR), Chi, Ai-Qiu1 (AUTHOR), Cai, Sheng-Yang1 (AUTHOR), Zhang, Ya-Meng1 (AUTHOR), Ren, Yu-Chen1 (AUTHOR), Lu, Xu1 (AUTHOR), Sun, Chen1 (AUTHOR), Mu, Xue-Pan1 (AUTHOR), Zhang, Igor Ying2 (AUTHOR), Weng, Jing-Wei3 (AUTHOR), Li, Meng-Yao1 (AUTHOR), Chen, Ying1 (AUTHOR), Zhu, Yi Zhun1,4,5 (AUTHOR) yzzhu@must.edu.mo, Tao, Bei-Bei1 (AUTHOR) taobeibei@fudan.edu.cn, Zhu, Yi-Chun1 (AUTHOR) yczhu@shmu.edu.cn |
| Source: | Free Radical Biology & Medicine. Aug2026, Vol. 251, p256-275. 20p. |
| Database: | Academic Search Ultimate |
| ISSN: | 08915849 |
|---|---|
| DOI: | 10.1016/j.freeradbiomed.2026.03.077 |
